Canada - Re-Export of Extracts of Glands for Therapeutic Use
Since 2014, Canada Re-Export of Extracts of Glands for Therapeutic Use was down by 77.8% year on year. With $183.09 in 2019, the country was ranked number 6 among other countries in Re-Export of Extracts of Glands for Therapeutic Use. United States topped the ranking with $266,511 in 2019, that is a fall of 17.2% versus 2018. Georgia, Saudi Arabia and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. United States recorded the best 5 years average growth at +9.1% per year, while Canada was the worst growing country at -77.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 183.09 |
| 2018 | 238,906.63 |
| 2017 | 171,854.08 |
| 2016 | 1,188,000.38 |
| 2015 | 6,143.07 |
Download all data from 2001 to 2019
How does Canada rank in Re-Export of Extracts of Glands for Therapeutic Use?
| # | 6 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
266,511.00 | 2019 | -17.2 % | +9.1 % | View data | |
| 2 |
#2
Georgia
|
73,777.45 | 2018 | NA | NA | View data | |
| 5 |
#5
New Zealand
|
311.12 | 2018 | NA | -22.2 % | View data | |
| 6 |
#6
Canada
|
183.09 | 2019 | -99.9 % | -77.8 % | View data | |